Join
Live feed
·
PRReleasevia Quantisnow
NewAmsterdam Pharma Company N.V. logo
Replimune Group Inc. logo

Forbion appoints Silva Deželan, PhD as Head of Impact and ESG

ByQuantisnow·Wall Street's wire, on your screen.
NAMS· NewAmsterdam Pharma Company N.V.REPL· Replimune Group Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.), REPL (Replimune Group Inc.) and more on Quantisnow.